UCSF research shows psychedelics like psilocybin may treat depression, Parkinson’s, and addiction, offering new hope in ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

Discover more about the benefit of psychedelic-assisted psychotherapy in reducing symptoms of depression and anxiety.

Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. A team of researchers at ...

A single dose of an investigational lysergic acid diethylamide (LSD)-based medication known as MM120 (lysergide D-tartrate, Mind Medicine Inc [MindMed]) was associated with a rapid and significant ...